1. Home
  2. YHC vs ONCO Comparison

YHC vs ONCO Comparison

Compare YHC & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc. Common Stock

YHC

LQR House Inc. Common Stock

HOLD

Current Price

$0.96

Market Cap

8.7M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$2.80

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YHC
ONCO
Founded
2021
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
4.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
YHC
ONCO
Price
$0.96
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
354.2K
31.1K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,103,341.00
$1,223,751.00
Revenue This Year
$69.97
N/A
Revenue Next Year
$403.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$2.10
52 Week High
$98.00
$179.35

Technical Indicators

Market Signals
Indicator
YHC
ONCO
Relative Strength Index (RSI) 56.10 51.35
Support Level $0.85 $2.45
Resistance Level $0.99 $3.15
Average True Range (ATR) 0.07 0.27
MACD 0.01 0.07
Stochastic Oscillator 71.46 66.66

Price Performance

Historical Comparison
YHC
ONCO

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: